MaxCyte Stock (NASDAQ:MXCT)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$3.45

52W Range

$3.17 - $5.54

50D Avg

$3.74

200D Avg

$4.18

Market Cap

$374.46M

Avg Vol (3M)

$416.21K

Beta

1.16

Div Yield

-

MXCT Company Profile


MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company was incorporated in 1998 and is headquartered in Rockville, Maryland.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

143

IPO Date

Jul 30, 2021

Website

MXCT Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 23Dec 22Dec 21
Other---
Product sales---

Fiscal year ends in Dec 23 | Currency in USD

MXCT Financial Summary


Dec 23Dec 22Dec 21
Revenue---
Operating Income---
Net Income---
EBITDA---
Basic EPS---
Diluted EPS---

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q3 24Nov 06, 24 | 10:01 PM
Q2 24Aug 07, 24 | 12:09 AM
Q1 24May 11, 24 | 8:35 AM

Peer Comparison


TickerCompany
ANIKAnika Therapeutics, Inc.
RPIDRapid Micro Biosystems, Inc.
IRMDIRadimed Corporation
OFIXOrthofix Medical Inc.
SGHTSight Sciences, Inc.
ITGRInteger Holdings Corporation
LUNGPulmonx Corporation
NPCENeuroPace, Inc.
SRDXSurmodics, Inc.
KIDSOrthoPediatrics Corp.
OSAProSomnus, Inc. Common Stock
CVRXCVRx, Inc.
CNMDCONMED Corporation